Article
A population-based survey of prostate-specific antigen testing among California men at higher risk for prostate carcinoma.
Cancer - 15 Feb 2006
Spencer Benjamin A, Babey Susan H, Etzioni David A, Ponce Ninez A, Brown E Richard, Yu Hongjian, Chawla Neetu, Litwin Mark S
Abstract excerpt
BACKGROUND: Despite the lack of evidence demonstrating a survival benefit from prostate-specific antigen (PSA) screening, its use has become widespread, organizations have encouraged physicians to discuss early detection of prostate carcinoma, and two higher risk groups have been recognized. In the current study, the authors examined whether African-American men and men who had a family history of prostate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.